SWOG clinical trial number
SWOG-8393 (INT-0013)

National Intergroup Protocol for Intermediate Thickness Melanomas 1.0 to 4.0 mm (MEL 82 323)

Closed
Phase
Published
Abbreviated Title
National Intergroup Protocol for Intermediate Thickness Melanomas 1.0 to 4.0 mm (MEL 82 323)
Activated
07/07/1983
Closed
03/15/1992

Research committees

Melanoma

Publication Information Expand/Collapse

2000

Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm)

CM Balch;SJ Soong;MI Ross;MM Urist;CP Karakousis;WJ Temple;MC Mihm;RL Barnhill;WR Jewell;HJ Wanebo;R Harrison Annals of Surgical Oncology 7(2):87-97

1996

Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 year of age and younger.

CM Balch;S Soong;AA Bartolucci;MM Urist;CP Karakousis;TJ Smith;WJ Temple;MI Ross;WR Jewell;MC Mihm Jr;RL Barnhill;HJ Wanebo Annals of Surgery 224(3):255-266

Surgical therapy of primary cutaneous melanoma.

PJ Geraghty;TM Johnson;VK Sondak;AE Chang Seminars in Surgical Oncology 12:386-393

Local recurrence in malignant melanoma: Long-term results of the multiinstitutional randomized surgical trial.

CP Karakousis;CM Balch;MM Urist;MM Ross;TJ Smith;AA Bartolucci Annals of Surgical Oncology 3(5):446-452

1995

Local recurrence in malignant melanoma: Long-term results of the surgical trial.

C Karakousis;C Balch;M Urist;M Ross;T Smith;A Bartalucci Proc of the 48th Annual Cancer Symposium of the Society of Surgical Oncology :6

A centimeter here, a centimeter there: Does it matter?

TM Johnson;VK Sondak Journal of the American Academy of Dermatology 33(3):532-534

1993

Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1-4 mm): Results of multi-institutional randomized surgical trial.

CM Balch;MM Urist;CP Karakousis;TJ Smith;WJ Temple;K Drzewiecki;WR Jewell;AA Bartolucci;MC Mihm Jr;R Barnhill;H Wanebo Annals of Surgery 218(3):262-269

Other Clinical Trials

SWOG Clinical Trial Number
S2000
SWOG Clinical Trial Number
CTSU/EA6174